Navigation Links
Ventana Supports World Patient Safety Day, July 25
Date:7/17/2012

TUCSON, Ariz., July 17, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will join thousands of patients, families, providers, and consumer groups worldwide in observing World Patient Safety Day on July 25 in tribute to those who work to improve the safety and quality of healthcare, and in memory of patients and families who have suffered from medical error.

(Photo: http://photos.prnewswire.com/prnh/20120717/LA41202)

A Southern Arizona-based supplier of automated diagnostic instrumentation and advanced tests, Ventana was established 25 years ago to improve the lives of all patients afflicted with cancer through scientific excellence and a relentless focus on innovation.

Watch the video: Ventana's Patient Safety Initiative.

"The spirit of this global initiative – to offer hope, healing and advocacy for safe healthcare, to save lives and to reduce healthcare costs through the elimination of preventable medical errors– is embodied in our Ventana mission to improve the lives of all patients afflicted with cancer," says Mara G. Aspinall, President, Ventana Medical Systems, Inc.

"As a global leader in helping hospitals, cancer centers, and laboratories worldwide improve patient care, Ventana salutes the organizers of World Patient Safety Day and supports their efforts to increase awareness of the vital importance of timely, accurate diagnosis and optimal treatment for every patient."

The Ventana portfolio of instruments and reagents not only provides accurate and speedy delivery of diagnostic results but also minimizes the risk of patient misidentification caused by mislabeling or tissue cross contamination.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

CONTACT: Jacqueline Bucher, Senior Director, Corporate Communications, +1-520-877-7288, jacquie.bucher@ventana.roche.com

 


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
2. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
3. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
4. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
7. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
8. Misonix Exhibits at Major Worldwide Spine Conference
9. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
10. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
11. World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... 28, 2016 New market ... is a report that provides an overview of ... pipelines by identifying new targets and MOAs to ... Profiles discussed in this H1 2016 Osteoarthritis Pipeline ... AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios ...
Breaking Medicine Technology:
(Date:4/30/2016)... Indianapolis, Indiana (PRWEB) , ... April 30, 2016 , ... ... USA Wrestling as they go for gold in Rio. Under the care of ... including two golds! , In an unprecedented showing, Maximized Living is sending the largest ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... the Accreditation Council for Graduate Medical Education (ACGME) that it has received accreditation ... the first accreditation of three residency programs that Memorial is currently pursuing, including ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related ... 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a plethora ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a ... proud to announce one of their physicians has been invited to be a featured ... ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. Scott ...
(Date:4/29/2016)... ... ... the deadliest type of skin cancer. Although only about 1 percent of skin cancer cases ... 10,000 people are expected to die of melanoma this year. The risk increases with age, ... most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may give ...
Breaking Medicine News(10 mins):